Ibrahim Batal

4.5k total citations
92 papers, 2.3k citations indexed

About

Ibrahim Batal is a scholar working on Nephrology, Transplantation and Molecular Biology. According to data from OpenAlex, Ibrahim Batal has authored 92 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Nephrology, 39 papers in Transplantation and 22 papers in Molecular Biology. Recurrent topics in Ibrahim Batal's work include Renal Diseases and Glomerulopathies (38 papers), Renal Transplantation Outcomes and Treatments (35 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (18 papers). Ibrahim Batal is often cited by papers focused on Renal Diseases and Glomerulopathies (38 papers), Renal Transplantation Outcomes and Treatments (35 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (18 papers). Ibrahim Batal collaborates with scholars based in United States, Canada and France. Ibrahim Batal's co-authors include Vivette D. D’Agati, Glen S. Markowitz, Dominick Santoriello, Satoru Kudose, Michael B. Stokes, Jonathan Barasch, Katherine Xu, Parmjeet Randhawa, Andrew S. Bomback and Sheldon Bastacky and has published in prestigious journals such as New England Journal of Medicine, Immunity and The Journal of Immunology.

In The Last Decade

Ibrahim Batal

88 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ibrahim Batal United States 29 793 638 532 526 439 92 2.3k
Stanislas Faguer France 28 657 0.8× 374 0.6× 339 0.6× 283 0.5× 531 1.2× 133 2.5k
Renaud Snanoudj France 28 539 0.7× 389 0.6× 302 0.6× 1.1k 2.0× 637 1.5× 84 2.4k
Évangéline Pillebout France 25 1.1k 1.4× 362 0.6× 295 0.6× 292 0.6× 391 0.9× 65 2.5k
Volker Witt Austria 21 332 0.4× 967 1.5× 470 0.9× 145 0.3× 456 1.0× 61 3.4k
Laura Connelly‐Smith United States 12 311 0.4× 784 1.2× 242 0.5× 134 0.3× 425 1.0× 32 2.6k
David Serur United States 24 684 0.9× 322 0.5× 143 0.3× 988 1.9× 937 2.1× 59 2.6k
Daniëlle Cohen Netherlands 24 261 0.3× 488 0.8× 362 0.7× 128 0.2× 197 0.4× 54 1.9k
Oriol Bestard Spain 32 509 0.6× 907 1.4× 278 0.5× 2.1k 4.0× 1.2k 2.7× 159 3.6k
Agnieszka Perkowska‐Ptasińska Poland 17 582 0.7× 219 0.3× 85 0.2× 685 1.3× 466 1.1× 84 1.6k
Nicolle H. R. Litjens Netherlands 30 277 0.3× 1.4k 2.2× 159 0.3× 609 1.2× 281 0.6× 80 2.7k

Countries citing papers authored by Ibrahim Batal

Since Specialization
Citations

This map shows the geographic impact of Ibrahim Batal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ibrahim Batal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ibrahim Batal more than expected).

Fields of papers citing papers by Ibrahim Batal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ibrahim Batal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ibrahim Batal. The network helps show where Ibrahim Batal may publish in the future.

Co-authorship network of co-authors of Ibrahim Batal

This figure shows the co-authorship network connecting the top 25 collaborators of Ibrahim Batal. A scholar is included among the top collaborators of Ibrahim Batal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ibrahim Batal. Ibrahim Batal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Şerban, Geo, Steven Thomas, Dominick Santoriello, et al.. (2024). Collapsing glomerulopathy is likely a major contributing factor for worse allograft survival in patients receiving kidney transplants from black donors. Frontiers in Medicine. 11. 1369225–1369225. 1 indexed citations
2.
Sethi, Sanjeev, Benjamin J. Madden, Marta Casal Moura, et al.. (2024). FAT1 is a target antigen in a subset of de novo allograft membranous nephropathy associated with antibody mediated rejection. Kidney International. 106(5). 985–990. 7 indexed citations
3.
Peleg, Yonatan, Miroslav Sekulic, Jae‐Hyung Chang, et al.. (2024). C3 Glomerulopathy Recurs Early after Kidney Transplantation in Serial Biopsies Performed within the First 2 Years after Transplantation. Clinical Journal of the American Society of Nephrology. 19(8). 1005–1015. 6 indexed citations
4.
Fernández, Hilda, et al.. (2024). Donor-derived membranous nephropathy in the allograft kidney: A rare but probably underestimated complication. American Journal of Transplantation. 24(12). 2292–2298.
5.
Batal, Ibrahim, Samih H. Nasr, Surendra Dasari, et al.. (2023). Pathologic-genomic correlation identified a novel variant in FN1 and established the diagnosis of recurrent fibronectin glomerulopathy in the kidney allograft. American Journal of Transplantation. 24(3). 498–502. 3 indexed citations
6.
Zanoni, Francesca, Pascale Khairallah, Krzysztof Kiryluk, & Ibrahim Batal. (2022). Glomerular Diseases of the Kidney Allograft: Toward a Precision Medicine Approach. Seminars in Nephrology. 42(1). 29–43. 6 indexed citations
7.
8.
Santoriello, Dominick, Andrew S. Bomback, Satoru Kudose, et al.. (2021). Anti-neutrophil cytoplasmic antibody associated glomerulonephritis complicating treatment with hydralazine. Kidney International. 100(2). 440–446. 23 indexed citations
9.
Sekulic, Miroslav, Satoru Kudose, Christine J. Kubin, et al.. (2021). Kidney allograft biopsy findings after COVID-19. American Journal of Transplantation. 21(12). 4032–4042. 21 indexed citations
10.
Brennan, Corey, Ibrahim Batal, Heather Morris, et al.. (2020). Treatment of borderline infiltrates with minimal inflammation in kidney transplant recipients has no effect on allograft or patient outcomes. Clinical Transplantation. 34(9). 74–75. 8 indexed citations
11.
Bomback, Andrew S., Michael B. Stokes, Dominick Santoriello, et al.. (2019). The spectrum of kidney biopsy findings in patients with morbid obesity. Kidney International. 95(3). 647–654. 31 indexed citations
12.
Batal, Ibrahim, et al.. (2018). Unusual case of levamisole-induced dual-positive ANCA vasculitis and crescentic glomerulonephritis. BMJ Case Reports. 2018. bcr–2018. 8 indexed citations
13.
14.
Lesage, Julie, Isabelle Côté, Éric Wagner, et al.. (2014). Donor-Specific Antibodies, C4d and Their Relationship With the Prognosis of Transplant Glomerulopathy. Transplantation. 99(1). 69–76. 37 indexed citations
15.
Venkatesh, Deepak, Thomas Ernandez, Florencia Rosetti, et al.. (2013). Endothelial TNF Receptor 2 Induces IRF1 Transcription Factor-Dependent Interferon-β Autocrine Signaling to Promote Monocyte Recruitment. Immunity. 38(5). 1025–1037. 109 indexed citations
16.
Batal, Ibrahim, Vanesa Bijol, Robert Schlossman, & Helmut G. Rennke. (2013). Proliferative Glomerulonephritis With Monoclonal Immunoglobulin Deposits in a Kidney Allograft. American Journal of Kidney Diseases. 63(2). 318–323. 10 indexed citations
17.
Batal, Ibrahim, Amit Basu, Henkie P. Tan, et al.. (2009). The significance of renal C4d staining in patients with BK viruria, viremia, and nephropathy. Modern Pathology. 22(11). 1468–1476. 25 indexed citations
18.
Batal, Ibrahim, Ron Shapiro, Amit Basu, et al.. (2009). Clinicopathologic analysis of patients with BK viruria and rejection-like graft dysfunction. Human Pathology. 40(9). 1312–1319. 18 indexed citations
19.
Batal, Ibrahim, Robyn T. Domsic, Aaron Shafer, et al.. (2008). Renal biopsy findings predicting outcome in scleroderma renal crisis. Human Pathology. 40(3). 332–340. 66 indexed citations
20.
Batal, Ibrahim, et al.. (2008). Deposition of Complement Product C4d in Anti–Glomerular Basement Membrane Glomerulonephritis. American Journal of Kidney Diseases. 53(6). 1098–1101. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026